Cite
HARVARD Citation
Bosio, A. et al. (2023). Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study. Clinical oncology. 35 (5), pp. e319-e327. [Online].